Ribonucleotide reductase inhibitors and methods of use

    公开(公告)号:US10155732B2

    公开(公告)日:2018-12-18

    申请号:US15725181

    申请日:2017-10-04

    申请人: City of Hope

    摘要: Provided herein are novel compounds that inhibit ribonucleotide reductase (RR) by binding to RRM2 and interfering with the activity of the RRM1/RRM2 holoenzyme, as well as methods of synthesizing these novel compounds. The compounds may be used to inhibit RR activity and to treat various conditions associated with RRM2 expression, such as for example certain cancer types, mitochondrial diseases, or degenerative diseases.